Found: 8
Select item for more details and to access through your institution.
Safety, tolerability, and preliminary efficacy of SAM-531, a 5HT-6 antagonist, in subjects with mild-to-moderate Alzheimer's disease: Results from a phase 2a study
- Published in:
- 2010
- By:
- Publication type:
- Abstract
PET imaging of β-amyloid with florpiramine F18 (18F-AV-45): Preliminary results from a phase II study of cognitively normal elderly subjects, individuals with mild cognitive impairment, and patients with a clinical diagnosis of Alzheimer's disease
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Relationship between regional amyloid levels and cognitive performance in healthy controls, MCI subjects, and patients with alzheimer's: Phase II results from a florpiramine F18 PET imaging study
- Published in:
- 2009
- By:
- Publication type:
- Abstract
P3-460: Safety, tolerability and pharmacokinetics of multiple doses of lecozotan in patients with Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P3-460: Safety, tolerability and pharmacokinetics of multiple doses of lecozotan in patients with Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2018, v. 75, n. 10, p. 1206, doi. 10.1001/jamaneurol.2018.1487
- By:
- Publication type:
- Article
Use of Flutemetamol F 18–Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment.
- Published in:
- JAMA Neurology, 2018, v. 75, n. 9, p. 1114, doi. 10.1001/jamaneurol.2018.0894
- By:
- Publication type:
- Article
Successful treatment of hemichorea with olanzapine.
- Published in:
- 1999
- By:
- Publication type:
- journal article